Literature DB >> 22266825

Sex-specific effects of spironolactone on blood pressure in gonadectomized male and female Wistar rats.

M Michaelis1, P J Hofmann, F Götz, C Bartel, T Kienitz, M Quinkler.   

Abstract

A low-salt diet is known to decrease and salt excess to increase blood pressure in humans and rodents. Sex steroids seem to play a role in salt dependent hypertension. However, little is known about sex differences in mineralocorticoid receptor blockade between male and female rats. The objective of the work was at first to investigate the effects of a low-salt vs. a high-salt diet on blood pressure without the influence of gonadal steroids in male and female rats. Second, to determine the sex-specific effects of mineralocorticoid receptor blockade by spironolactone in high-salt and low-salt fed gonadectomized male and female animals. Normotensive male and female Wistar rats were gonadectomized and put on a low (NaCl<0.03%) or high (NaCl=4%) salt diet. On each diet animals received spironolactone or placebo. Blood pressure was measured by tail-cuff-method; 24-h urine samples were collected in metabolic cages and blood was collected for hormonal measurements. High-salt diet significantly increased systolic blood pressure in both sexes. This effect could be blocked effectively by spironolactone only in male rats. Spironolactone treatment significantly increased aldosterone levels in males and females independent of the sodium content of the diet. High sodium diet significantly increased relative kidney weight, which was not altered by spironolactone treatment. Independently of gonadal steroids a high-salt diet increased blood pressure in gonadectomized male and female rats. Spironolactone lowered blood pressure only in male not in female rats on a high-salt diet clearly indicating sex-specific effects of the mineralo-corticoid antagonist spironolactone. © Georg Thieme Verlag KG Stuttgart · New York.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22266825     DOI: 10.1055/s-0031-1299774

Source DB:  PubMed          Journal:  Horm Metab Res        ISSN: 0018-5043            Impact factor:   2.936


  5 in total

1.  The mineralocorticoid receptor antagonist spironolactone reduces alcohol self-administration in female and male rats.

Authors:  Viren H Makhijani; Kalynn Van Voorhies; Joyce Besheer
Journal:  Pharmacol Biochem Behav       Date:  2018-08-29       Impact factor: 3.533

Review 2.  The endothelial mineralocorticoid receptor: Contributions to sex differences in cardiovascular disease.

Authors:  M Elizabeth Moss; Brigett Carvajal; Iris Z Jaffe
Journal:  Pharmacol Ther       Date:  2019-07-02       Impact factor: 12.310

Review 3.  Pharmacogenomics, pharmacokinetics and pharmacodynamics: interaction with biological differences between men and women.

Authors:  Flavia Franconi; Ilaria Campesi
Journal:  Br J Pharmacol       Date:  2014-02       Impact factor: 8.739

4.  SPIRONOLACTONE FOR NONRESOLVING CENTRAL SEROUS CHORIORETINOPATHY: A RANDOMIZED CONTROLLED CROSSOVER STUDY.

Authors:  Elodie Bousquet; Talal Beydoun; Pierre-Raphaël Rothschild; Ciara Bergin; Min Zhao; Rui Batista; Marie-Laure Brandely; Benedicte Couraud; Nicolette Farman; Alain Gaudric; François Chast; Francine Behar-Cohen
Journal:  Retina       Date:  2015-12       Impact factor: 4.256

5.  Myeloid mineralocorticoid receptor during experimental ischemic stroke: effects of model and sex.

Authors:  Ryan A Frieler; Jessica J Ray; He Meng; Sai P Ramnarayanan; Michael G Usher; Enming J Su; Stefan Berger; David J Pinsky; Daniel A Lawrence; Michael M Wang; Richard M Mortensen
Journal:  J Am Heart Assoc       Date:  2012-10-25       Impact factor: 5.501

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.